February 18, 2021 The reckoning begins for biotech-focused Spacs The clock is ticking for the flood of blank-cheque companies that raised money last year, and competition is only getting hotter.
September 30, 2020 More biotechs test the third way to market Formation of Spacs – special-purpose acquisition companies – is surging, but will fierce competition for deals hurt performance?
